secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0001493152-24-047421
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical faces Nasdaq delisting over late Q3 2024 10-Q; hearing Dec 16
------------------------------------------------------------------------------

- Received Nasdaq notice on Nov 18, 2024 for failure to file Form 10-Q for period ended Sep 30, 2024.
- This is an additional basis for delisting; prior delinquencies include 2023 10-K and Q1/Q2 2024 10-Qs.
- Nasdaq Hearings Panel will consider the matter at hearing scheduled for December 16, 2024.
- Company intends to file delinquent reports as soon as practicable; no immediate effect on trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224047421/0001493152-24-047421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224047421/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer